Introduction {#s1}
============

The striatum is critically involved in value-based decision making, which consists of two distinct steps: value-based action selection and value updating based on choice outcomes. A large body of evidence indicates the involvement of the striatum in both of these processes ([@bib3]; [@bib18]; [@bib20]; [@bib30]; [@bib33]). Striatal spiny projection neurons (SPNs) are divided into two distinct groups according to their output projections. In rodents, direct-pathway SPNs project directly to the endopeduncular nucleus (EP; homologous to the globus pallidus interna in primates) and the substantia nigra pars reticulata (SNr), and indirect-pathway SPNs project indirectly to the EP/SNr via the globus pallidus (GP) and subthalamic nucleus ([@bib42]). The two groups of striatal neurons also differ in their gene expression patterns. Direct-pathway striatal neurons selectively express D1 receptors (D1R), whereas indirect-pathway striatal neurons express D2 receptors (D2R) ([@bib15]), although such a segregation is less strict in the ventral striatum ([@bib43]). Selectively manipulating striatal D1R (or direct-pathway SPNs) versus D2R (or indirect-pathway SPNs) affects reward-based learning and goal-directed behavior differently ([@bib16]; [@bib27]; [@bib31]; [@bib36]; [@bib38]; [@bib46]; [@bib49]), suggesting distinct roles of direct and indirect pathways in value-based decision making. However, it is unclear how the direct and indirect pathways of the striatum work together to control value-based action selection and value updating. In the present study, to obtain insights on the roles of striatal direct and indirect pathway neurons in these processes, we selectively inactivated D1R- or D2R-expressing dorsal striatal neurons and examined subsequent effects on mouse choice behavior in reversal and dynamic foraging tasks. We found a double dissociation in the effects of inactivating D1R- versus D2R-expressing striatal neurons: D1R neuronal inactivation reduced value-dependent action selection and D2R neuronal inactivation reduced value learning, with neither affecting the other process. Our results indicate that D1R- and D2R-expressing dorsal striatal neurons are indispensable for two different steps in value-based decision making.

Results {#s2}
=======

Reversal task {#s2-1}
-------------

We used mice harboring a D1R-Cre or D2R-Cre construct to selectively inactivate D1R- or D2R-expressing striatal neurons, respectively. We bilaterally injected a double-floxed (DIO) Cre-dependent adeno-associated virus (AAV) vector carrying a modified form of the human M4 muscarinic receptor (DIO-hM4Di-mCherry) into the dorsal striatum of 31 D1R-Cre and 30 D2R-Cre mice. As controls, we bilaterally injected AAV virus carrying enhanced green fluorescent protein (DIO-eGFP) into the dorsal striatum of separate groups of D1R-Cre and D2R-Cre mice (n = 5 each). Histological examinations after completion of behavioral experiments revealed that mCherry and eGFP were expressed in the dorsal striatum and EP in D1R-Cre mice and in the dorsal striatum and GP in D2R-Cre mice, confirming their selective expression in direct- or indirect-pathway SPNs, respectively ([Figure 1](#fig1){ref-type="fig"}).

![Selective expression of h4MDi-mCherry and eGFP in direct- or indirect-pathway striatal neurons.\
(**a**) Representative brain sections showing h4MDi-mCherry expression in the dorsal striatum and EP in D1R-Cre mice (left), and in the dorsal striatum and GP in D2R-Cre mice (right). (**b**) Representative brain sections showing eGFP expression in the dorsal striatum and EP in D1R-Cre mice (left), and in the dorsal striatum and GP in D2R-Cre mice (right).](elife-46050-fig1){#fig1}

Twenty or 21 d after virus injection, D1R-Cre (n = 26) and D2R-Cre (n = 26) mice were trained in a reversal task in an operant chamber with progressively increasing reversal frequency. This was a self-paced instrumental learning task in which the animal initiates a trial by poking its nose into the central hole and then chooses freely either the left or right nose-poke hole to obtain a water reward ([Figure 2a](#fig2){ref-type="fig"}). D1R-Cre and D2R-Cre mice were each divided into three groups---CNO group, in which clozapine-N-oxide (CNO) was injected into hM4Di-expressing mice; DMSO group, in which dimethyl sulfoxide (DMSO, vehicle) was injected into hM4Di-expressing mice; and eGFP-CNO group, in which CNO was injected into eGFP-expressing mice (D1R-Cre mice, n = 11, 10 and 5 for CNO, DMSO and eGFP-CNO groups, respectively; D2R-Cre mice, n = 11, 10 and 5 for CNO, DMSO and eGFP-CNO groups, respectively). Mice were intraperitoneally injected daily with DMSO (2.5--3%, 0.5 ml/kg) or CNO (5 mg/kg) 40 min prior to behavioral testing. For each training stage and each animal group, sessions with mean trial durations greater than three standard deviations (SDs) from the mean of the corresponding population (i.e., trial-duration outliers) were excluded from the analysis (total deleted sessions: D1R-Cre mice, 4 of 190 DMSO sessions, 7 of 209 CNO sessions and 0 of 95 eGFP-CNO sessions; D2R-Cre mice: 3 of 190 DMSO sessions, 5 of 209 CNO sessions and 1 of 95 eGFP-CNO sessions).

![Behavioral performance in the reversal task.\
(**a**) Behavioral task. Following nose poke in the lit central hole, the animal was allowed to choose freely between two targets to obtain a water reward. (**b**) Daily performances (means ± SEM across animals) of the three animal groups (CNO, DMSO and eGFP-CNO) are shown separately for D1R-Cre and D2R-Cre mice. (**c**) Mean (± SEM across animals) performances of the three animal groups during each stage. Circles, data for individual animals. *P*-values are indicated for the main effect of animal group (Group) and the effect of mouse line ×animal group interaction (Intx) (two-way between-groups ANOVA). Asterisks indicate the results of Bonferroni post-hoc tests (\*\*p\<0.01; \*\*\*p\<0.001).](elife-46050-fig2){#fig2}

All animal groups learned to choose the rewarding target (either left or right; counterbalanced across animals) during the initial 3 d of training (stage 1). After reversal of the rewarding target, all animal groups learned to choose the other rewarding target over 4 d of training (stage 2). Performances of the three animal groups were also similar during across-session reversal (reversal of the rewarding target at the beginning of each daily session; stage 3; two-way between-groups ANOVA, main effect of mouse line, F(1,46) = 2.8, p = 0.101; main effect of animal group, F(2,46) = 2.04, p = 0.141; mouse line × animal group interaction, F(2,46) = 0.15, p = 0.858). However, performance of the CNO group was significantly lower compared with other animal groups in stage 4 (main effect of mouse line, F(1,46) = 3.64, p = 0.063; main effect of animal group, F(2,46) = 58.54, p = 2.3 × 10^−13^; mouse line × animal group interaction, F(2,46) = 3.58, p = 0.036; post-hoc Bonferroni test, D1R-Cre mice, CNO vs. DMSO, p = 9.9 × 10^−8^, CNO vs. eGFP-CNO, p = 2.1 × 10^−8^, DMSO vs. eGFP-CNO, p = 0.089; D2R-Cre mice, CNO vs. DMSO, p = 0.003, CNO vs. eGFP-CNO, p = 3.6 × 10^−5^, DMSO vs. eGFP-CNO, p = 0.326) and stage 5 (main effect of mouse line, F(1,46) = 0.11, p = 0.747; main effect of animal group, F(2,46) = 39.32, p = 1.1 × 10^−10^; mouse line × animal group interaction, F(2,46) = 0.05, p = 0.954; post-hoc Bonferroni test, CNO vs. DMSO, p = 2.1 × 10^−8^, CNO vs. eGFP-CNO, p = 2.9 × 10^−9^, DMSO vs. eGFP-CNO, p = 0.195; [Figure 2b,c](#fig2){ref-type="fig"}), in which the target location was changed one or two times during each daily session (within-session reversal). Mean trial durations varied substantially so that it was difficult to match them across the three animal groups. However, further analysis revealed that the performance deficits following D1R or D2R neuronal inactivation could not be attributed to differences in trial duration across animal groups ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). In sum, mice in all groups learned to choose the rewarding target as long as the location of the rewarding target did not change within a session. However, as the frequency of reversal increased such that the target location changed within a session, the performance of the CNO group became significantly impaired relative to that of the other groups.

Dynamic two-armed bandit task {#s2-2}
-----------------------------

Having established that inactivation of D1R- or D2R-expressing striatal neurons impairs reversal learning and that this is not attributable to a nonspecific effect of CNO using separate groups of animals, we examined effects of inactivating D1R- or D2R-expressing striatal neurons in a dynamic two-armed bandit (TAB) task ([Figure 3a](#fig3){ref-type="fig"}) by injecting the same animal with DMSO and CNO on alternative days prior to daily sessions (10 sessions each). This allowed us to make within-subject comparisons between the effects of CNO and DMSO injection. We used some animals (five CNO and five DMSO D1R-Cre mice; five CNO and five DMSO D2R-Cre mice) that had been used in the reversal task (\>7 d interval between the two tasks) as well as naive animals (10 D1R-Cre and nine D2R-Cre mice). For each treatment group, sessions with mean trial durations \> 3 SDs from the mean of the corresponding treatment group were excluded from the analysis (deleted sessions: D1R-Cre mice, 3 of 200 DMSO sessions and 2 of 200 CNO sessions; D2R-Cre mice: 4 of 190 DMSO sessions and 6 of 190 CNO sessions). In addition, mean trial durations were matched between CNO and DMSO sessions by deleting long trial-duration CNO sessions (D1R-Cre mice, 24 of 198; D2R-Cre mice, 17 of 184) and short trial-duration DMSO sessions (D1R-Cre mice, 20 of 197; D2R-Cre mice, 4 of 186).

![Behavioral performance in the dynamic TAB task.\
(**a**) Representative TAB-task session (D1R-Cre mouse with DMSO injection). Tick marks indicate trial-by-trial choices of the animal (top, left choice; bottom, right choice; long, rewarded; short, unrewarded). Gray vertical lines denote block transitions. Numbers indicate block reward probabilities of left and right targets. The gray line indicates actual choices of the animal, shown as the probability of choosing the left goal (*P~L~*) in a moving average of 10 trials. The black line indicates *P~L~*, predicted by the Q-learning model. (**b--d**) Proportions (%) of rewarded trials (P(R)), higher-reward--probability target choices (P(H)), win-stay (P(WS)), and lose-switch (P(LS)) were compared between DMSO and CNO sessions for all trials (**b**), dynamic-state trials (**c**), and steady-state trials (**d**) (means ± SEM across animals). Gray circles and connecting lines, individual animal data. *P*-values are indicated for those measures with significant main effects of drug and/or mouse line × drug interaction (Intx) effects (two-way mixed-design ANOVA). Asterisks indicate the results of Bonferroni post-hoc tests (\*\*p\<0.01; \*\*\*p\<0.001).](elife-46050-fig3){#fig3}

In the dynamic TAB task, each choice was associated with a different probability of reward that was kept constant within a block of trials, but changed across blocks without any sensory cues. Hence, the task required the animal to discover reward probabilities and the optimal choice based on the history of past choices and their outcomes. As shown previously in a similar TAB task ([@bib22]), the probability of choosing the lower-reward--probability target did not increase as a block transition approached, arguing against the possibility that animals were able to estimate the time of reversal ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Consistent with this finding, animal choice behavior in this task was well captured by the Q-learning model, a simple reinforcement learning model ([@bib45]) ([Figure 3a](#fig3){ref-type="fig"}). All animals were over-trained in the TAB task (\~3 wk) before drug injection. CNO and DMSO were then injected on alternate days with either drug injected on the first day (counterbalanced across animals). We assessed behavioral performance by examining the proportions of rewarded trials and higher-reward--probability target choices (P(R) and P(H), respectively). We found a significant main effect of drug without a significant mouse line × drug interaction effect on P(R) (two-way mixed-design ANOVA, main effect of mouse line, F(1,37) = 6.214, p = 0.017; main effect of drug, F(1,37) = 32.636, p = 1.5 × 10^−6^; mouse line × drug interaction, F(1,37) = 0.530, p = 0.471) as well as P(H) (main effect of mouse line, F(1,37) = 4.020, p = 0.052; main effect of drug, F(1,37) = 31.591, p = 2.1 × 10^−6^; mouse line × drug interaction, F(1,37) = 0.0004, p = 0.984; [Figure 3b](#fig3){ref-type="fig"}). These results indicate that inactivating either D1R- or D2R-expressing striatal neurons impairs performance in the TAB task.

To explore how D1R- and D2R-expressing neuronal inactivation impairs performance in the TAB task, we examined whether CNO effects differ between D1R-Cre and D2R-Cre mice. For this, we separately analyzed animal choice behavior in the dynamic and steady states (early and late trials after block transition, respectively; see Materials and methods) between which relative contributions of two major processes of value-based decision making, namely value-updating and value-dependent action-selection, to choice behavior are likely to vary. We examined whether choice-related measures, P(R) and P(H) along with the proportions of win-stay and lose-switch (P(WS) and P(LS), respectively), show significant mouse line × drug interaction effects in the dynamic or steady state. In the dynamic state, we found a significant mouse line × drug interaction effect on P(R) (two-way mixed-design ANOVA, main effect of mouse line, F(1,37) = 6.719, p = 0.014; main effect of drug, F(1,37) = 14.76, p = 4.6 × 10^−4^; mouse line × drug interaction, F(1,37) = 4.5128, p = 0.040), but not on the other measures (P(H), main effect of mouse line, F(1,37) = 10.469, p = 0.003; main effect of drug, F(1,37) = 2.636, p = 0.113; mouse line × drug interaction, F(1,37) = 1.0276, p = 0.317; P(WS), main effect of mouse line, F(1,37) = 2.216, p = 0.145; main effect of drug, F(1,37) = 3.4168, p = 0.073; mouse line × drug interaction, F(1,37) = 0.19866, p = 0.658; P(LS), main effect of mouse line, F(1,37) = 0.157, p = 0.694; main effect of drug, F(1,37) = 0.6003, p = 0.443; mouse line × drug interaction, F(1,37) = 2.5894, p = 0.116). Post-hoc Bonferroni tests revealed a significant CNO effect on P(R) in D2R-Cre, but not D1R-Cre, mice (p = 1.8 × 10^−4^ and 0.226, respectively; [Figure 3c](#fig3){ref-type="fig"}).

In the steady state, we found significant mouse line × drug interaction effects on P(H) (main effect of mouse line, F(1,37) = 0.009, p = 0.926; main effect of drug, F(1,37) = 9.0145, p = 0.005; mouse line × drug interaction, F(1,37) = 5.1513, p = 0.029) and P(LS) (main effect of mouse line, F(1,37) = 0.853, p = 0.362; main effect of drug, F(1,37) = 2.9786, p = 0.093; mouse line × drug interaction, F(1,37) = 8.735, p = 0.005), but not on P(R) (main effect of mouse line, F(1,37) = 0.921, p = 0.344; main effect of drug, F(1,37) = 5.6916, p = 0.022; mouse line × drug interaction, F(1,37) = 1.6644, p = 0.205) or P(WS) (main effect of mouse line, F(1,37) = 0.094, p = 0.761; main effect of drug, F(1,37) = 13.05, p = 9.0 × 10^−4^; mouse line × drug interaction, F(1,37) = 4.0786, p = 0.051). Post-hoc Bonferroni tests revealed significant CNO effects on P(H) and P(LS) in D1R-Cre, but not D2R-Cre, mice (P(H), p = 5.6 × 10^−4^ and 0.612 in D1R-Cre and D2R-Cre mice, respectively; P(LS), p = 0.002 and 0.396, respectively). Because the effect of mouse line × drug interaction on P(WS) was near the conventional criterion for significance (p = 0.051), we also performed post-hoc tests for this measure. CNO effect on P(WS) was significant in D1R-Cre, but not D2R-Cre, mice (p = 2.6 × 10^−4^ and 0.273, respectively; [Figure 3c](#fig3){ref-type="fig"}). In sum, we found CNO effects that are selective between D1R-Cre and D2R-Cre mice for some behavioral measures. CNO significantly decreased P(R) in D2R-Cre, but not D1R-Cre, mice in the dynamic state, and significantly decreased P(H), P(WS) and P(LS) in D1R-Cre, but not D2R-Cre, mice in the steady state. To test the likelihood of finding three or more significant interaction effects by chance, we randomly assigned D1-Cre and D2R-Cre mice into two animal groups and repeated the same analysis (total eight ANOVAs; P(R), P(H), P(WS) and P(LS) in the dynamic and steady states). Out of 100 such permutations, we found no case in which significant animal group × drug interaction effect was found in three or more ANOVAs, indicating that our finding is unlikely to be obtained by chance.

Model-based analysis {#s2-3}
--------------------

Differences in the pattern of CNO effects on animal choice behavior during dynamic and steady states between D1R-Cre and D2R-Cre mice raises the possibility that D1R- and D2R-expressing striatal neurons may contribute differently to the neural processes underlying value-based decision making. To further explore this possibility, we analyzed animal-choice data using the Q-learning model, a reinforcement learning model that has two free parameters: learning rate (α) and randomness in action selection (β). The former determines the extent to which newly acquired information overrides old information, and the latter determines the degree of value-dependent action selection. We found that CNO significantly increased the randomness in action selection (or decreased value-dependent action selection) in D1R-Cre, but not D2R-Cre, mice (two-way mixed-design ANOVA, main effect of mouse line, F(1,37) = 0.398, p = 0.532; main effect of drug, F(1,37) = 8.8886, p = 0.005; mouse line × drug interaction, F(1,37) = 7.2601, p = 0.011; post-hoc Bonferroni test, CNO vs. DMSO, D1R-Cre mice, p = 2.4 × 10^−4^, D2R-Cre mice, p = 0.842). We also found that CNO significantly decreased learning rate in D2R-Cre, but not D1R-Cre, mice (main effect of mouse line, F(1,37) = 1.303, p = 0.261; main effect of drug, F(1,37) = 6.4289, p = 0.016; mouse line × drug interaction, F(1,37) = 5.9142, p = 0.020; post-hoc Bonferroni test, CNO vs. DMSO, D1R-Cre mice, p = 0.941, D2R-Cre mice, p = 0.001; [Figure 4a](#fig4){ref-type="fig"}). These results were consistent across several variants of the Q-learning model containing additional parameters ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}; see [Supplementary file 1](#supp1){ref-type="supplementary-material"} for results of model comparisons). Collectively, these findings indicate that inactivation of D1R-expressing striatal neurons selectively impairs value-dependent action selection and inactivation of D2R-expressing striatal neurons selectively impairs value learning.

![Effects of CNO on learning rate and randomness in action selection.\
(**a**) Learning rate (α) and randomness in action selection (β), estimated from behavioral data during the TAB task, were compared between DMSO and CNO sessions (means ± SEM across animals). (**b**) Top, trial-by-trial action values during the initial 15 trials after block transition. Bottom, mean (± SEM across animals) action values in the dynamic state. (**c**) Top, trial-by-trial action values during the last 10 trials of a block. Bottom, mean (± SEM across animals) action values in the steady state. Gray circles and connecting lines, individual animal data. Asterisks indicate the results of Bonferroni post-hoc tests (\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001) for those measures with significant mouse line × drug interaction (Intx) effects (two-way mixed-design ANOVA).](elife-46050-fig4){#fig4}

We also tested predictions of the above findings. In D2R-Cre mice, CNO is expected to slow the rate of action value change across trials after block transition because learning rate is reduced. However, during late trials after block transition (i.e., after sufficient learning), the magnitude of action values should be similar between CNO- and DMSO-injected sessions. In D1R-Cre mice, the effect of CNO on action value is expected to be weak because any effect of CNO on action value would be only indirect via its effect on action selection. To test these predictions, we compared action values for high- and low-probability reward targets (*Q~high~* and *Q~low~*, respectively) between CNO and DMSO sessions for the initial 15 trials after block transition and the last 10 trials before block transition. We used blocks 2--4 for this analysis. *Q~high~* changed more slowly after block transition in CNO than DMSO sessions such that the mean *Q~high~* value in the dynamic state was significantly smaller in CNO compared with DMSO sessions in D2R-Cre, but not D1R-Cre, mice (two-way mixed-design ANOVA, main effect of mouse line, F(1,37) = 12.133, p = 0.001; main effect of drug, F(1,37) = 5.5095, p = 0.024; mouse line × drug interaction, F(1,37) = 14.147, p = 5.8 × 10^−4^; post-hoc Bonferroni test, CNO vs. DMSO, D1R-Cre mice, p = 0.318, D2R-Cre mice, p = 1.3 × 10^−4^; [Figure 4b](#fig4){ref-type="fig"}). In D1R-Cre mice, *Q~high~* was slightly higher during a few trials after block transition in CNO sessions compared with DMSO sessions ([Figure 4b](#fig4){ref-type="fig"}), but this can be explained by less value-dependent action selection in CNO sessions (i.e., greater chance of choosing the higher-reward--probability target immediately after block transition), which would increase the chance of updating the action value of the higher-reward--probability target. No significant effect of CNO was found on *Q~low~* after block transition (main effect of mouse line, F(1,37) = 0.299, p = 0.588; main effect of drug, F(1,37) = 0.2265, p = 0.637; mouse line × drug interaction, F(1,37) = 0.2891, p = 0.594; [Figure 4b](#fig4){ref-type="fig"}), suggesting preferential contributions of striatal D2R-expressing neurons to learning from positive outcomes ([@bib5]; [@bib11]) (see also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). As expected, *Q~high~* and *Q~low~* were similar between CNO and DMSO sessions in the steady state in D1R-Cre as well as D2R-Cre mice (*Q~high~*, main effect of mouse line, F(1,37) = 4.881, p = 0.033; main effect of drug, F(1,37) = 0.54679, p = 0.464; mouse line × drug interaction, F(1,37) = 0.57919, p = 0.452; *Q~low~*, main effect of mouse line, F(1,37) = 1.786, p = 0.190; main effect of drug, F(1,37) = 0.64447, p = 0.427; mouse line × drug interaction, F(1,37) = 0.41336, p = 0.524; [Figure 4c](#fig4){ref-type="fig"}). These results are consistent with the possibility that inactivation of D1R-expressing striatal neurons selectively impairs value-dependent action selection, whereas inactivation of D2R-expressing striatal neurons impairs value learning.

Discussion {#s3}
==========

We found D1R neuronal inactivation decreases the degree of value-dependent action selection without affecting learning rate, whereas D2R neuronal inactivation decreases learning rate without affecting value-dependent action selection. These findings suggest that dorsal striatal direct and indirect pathways might play crucial roles in distinct stages of value-based decision making. Even though we did not test eGFP-CNO mice in the dynamic foraging task, selective effects of CNO on D1R-Cre versus D2R-Cre mice (as opposed to common CNO effects on both mouse lines) argue against non-specific effects of CNO. We also failed to find nonspecific effects of CNO on learning rate or randomness in action selection in our previous study ([@bib22]). There remains a possibility that inactivation of D1R- and/or D2R-expressing striatal interneurons (GABAergic fast-spiking interneurons and cholinergic tonically active neurons) might have contributed to the observed behavioral effects. However, this is unlikely because similar, small percentages of parvalbumin-positive and choline acetyltransferase-positive striatal neurons are labeled in D1R-Cre and D2R-Cre mice ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; see also [@bib41]). Previous theories on circuit operations of the basal ganglia have focused on relative contributions of direct and indirect pathways to controlling actions in the same domain ([@bib1]; [@bib2]; [@bib9]; [@bib12]; [@bib17]; [@bib28]; [@bib35]; [@bib37]; [@bib44]). Our results raise the possibility that direct and indirect pathways play more important roles in different domains of decision making. One limitation of our study is the lack of precisely timed manipulation of striatal neuronal activity, which would be useful for gaining insight into the roles played by specific activity patterns of D1R- and D2R-expressing striatal neurons and their interactions with dopamine circuits in decision making. Future studies employing manipulation techniques that allow precisely timed manipulation of striatal neural activity, such as optogenetics, may provide useful information in this regard.

We have shown previously that value learning is impaired in D2R-knockout mice, but not D1R-knockout mice ([@bib29]). There also exists a large body of literature indicating a role for D2R in reversal learning, although D1R has also been implicated in this process ([@bib21]; [@bib25]; [@bib48]). Reversal learning is also impaired by selectively inactivating striatal neurons in the indirect pathway, but not the direct pathway ([@bib39]; [@bib49]). Furthermore, indirect pathway striatal SPNs carry stronger previous reward signals than direct pathway SPNs in mice ([@bib41]); and in monkeys, striatal injection of a D2R, but not D1R, antagonist impairs learning from past outcomes ([@bib31]). These studies are consistent with the current findings, which suggest a critical role of the striatal indirect pathway in mediating value learning.

It has been proposed that direct- and indirect-pathway striatal neurons mediate learning from positive and negative outcomes, respectively ([@bib13]; [@bib12]). Our results are inconsistent with this proposal in that inactivating D1R-expressing striatal neurons had no significant effect on learning rate. Our results are also inconsistent with this proposal in that inactivating D2R-expressing striatal neurons impaired learning from positive outcomes. The effect of inactivating D2R-expressing striatal neurons on the action value for a high-reward--probability target (*Q~high~*) was much greater than that for a low-reward--probability target (*Q~low~*) after block transition. Furthermore, using models containing separate learning parameters for positive and negative outcomes (α~p~ and α~n~, respectively; models 3, 5 and 6), we found a significant reduction in α~p~, but not α~n~, following inactivation of D2R-expressing striatal neurons. These results suggest that D2R-expressing striatal neurons play a more important role in learning from positive than negative outcomes.

Dopamine has long been proposed to play a role in gain control and modulation of corticostriatal action selection processes ([@bib6]; [@bib34]; [@bib40]). In particular, a previous modeling study proposed that tonic dopamine regulates randomness in action selection via D1R-expressing, but not D2R-expressing, striatal neurons ([@bib19]), a suggestion consistent with our findings. A recent study has also shown that activating striatal direct and indirect pathways alters the gain of cortical motor commands ([@bib51]). Our results also support roles of striatal neurons in gain control. Changing the randomness in action selection (β) is equivalent to changing the gain of value-dependent action selection without altering action values (see [Equation 2](#equ2){ref-type="disp-formula"}). Likewise, changing learning rate (α) is equivalent to changing the gain of reward prediction error (RPE)-dependent learning (see [Equation 1](#equ1){ref-type="disp-formula"}; note that *RPE* = *R(t) -- Q~a~(t)*). Our results suggest that striatal direct and indirect pathways may be involved in controlling the gain, not only of motor commands, but also of value-based decision making. Considering that stimulation of D1R- and D2R-expressing SPNs induces distinct patterns of responses in downstream structures ([@bib32]), inactivation of these SPN subtypes is likely to exert distinct effects on downstream structures as well. It remains to be determined how D1R- or D2R-expressing striatal neuronal inactivation affects downstream structures, such as the EP, SNr, thalamus, and motor cortical areas so as to compromise value learning or value-dependent action selection.

Our results are not entirely consistent with previous findings. We previously showed that both D1R- and D2R-expressing SPNs convey value and RPE signals, which would suggest their involvement in both value-dependent action selection and value-updating processes. In particular, the activity of D1R- and D2R-expressing SPN populations increases and decreases, respectively, as a function of value ([@bib41]), which fits well with the antagonistic effects of striatal D1R versus D2R (or direct versus indirect pathway SPN) manipulations on reward-based learning ([@bib16]; [@bib27]; [@bib36]; [@bib46]; [@bib49]). Likewise, antagonistic effects of D1R- versus D2R-expressing SPN stimulation on motor behavior have been reported ([@bib10]; [@bib26]; [@bib51]). However, in the present study, inactivation of D1R- or D2R-expressing SPNs impaired two different aspects of value-based decision making. It may be that both direct and indirect pathways are involved in action selection and value learning, but D1R (or D2R)-expressing SPNs alone may be sufficient to support value-dependent action selection (or value updating), such that strong stimulation yields antagonistic effects whereas inactivation yields selective effects. Alternatively, the direct and indirect pathways may play selective roles, and seemingly antagonistic stimulation effects are because of indirect effects of strong, potentially non-physiological, stimulation. Note that direct and indirect pathway striatal neurons often exhibit activity that cannot be explained by a simple antagonistic or synergistic relationship between the two pathways (e.g., [@bib7]; [@bib8]; [@bib41]). Likewise, direct and indirect pathway manipulations often lead to behavioral outcomes that cannot be readily explained by their antagonistic or synergistic actions (e.g., [@bib23]; [@bib47]). Also note that we inactivated both the dorsomedial and dorsolateral striatum, which are likely to make substantially different contributions to behavioral control ([@bib4]; [@bib20]; [@bib24]; [@bib50]). Clearly, further studies are needed to make coherent sense of all these findings and to understand how striatal direct and indirect pathways work together to contribute to making optimal choices in a dynamic and uncertain environment.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                Designation                         Source or\                                                                Identifiers                                                                Additional\
  (species) or\                                                                    reference                                                                                                                                            information
  resource                                                                                                                                                                                                                              
  -------------------------------------------- ----------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------- -------------
  Strain, strain background (*Mus musculus*)   STOCK Tg(Drd1-cre)EY217Gsat/Mmucd   Gene Expression Nervous System Atlas                                      RRID:[MMRRC_030778-UCD](https://scicrunch.org/resolver/MMRRC_030778-UCD)   

  Strain, strain background (*Mus musculus*)   STOCK Tg(Drd2-cre)ER44Gsat/Mmucd    Gene Expression Nervous System Atlas                                      RRID:[MMRRC_017263-UCD](https://scicrunch.org/resolver/MMRRC_017263-UCD)   

  Recombinant DNA reagent                      AAV8-hSyn-DIO-hM4Di-mCherry         Addgene (PMID:[21364278](https://www.ncbi.nlm.nih.gov/pubmed/21364278))   RRID:[Addgene_44362](https://scicrunch.org/resolver/Addgene_44362)         

  Recombinant DNA reagent                      AAV2-hSyn-DIO-eGFP                  Addgene                                                                   RRID:[Addgene_50457](https://scicrunch.org/resolver/Addgene_50457)         

  Chemical compound, drug                      clozapine-N-oxide                   TOCRIS                                                                    Cat. \#:4936                                                               

  Chemical compound, drug                      dimethyl sulfoxide                  TOCRIS                                                                    Cat. \#:3176                                                               

  Software, algorithm                          Matlab 9.4                          Matworks                                                                  R2018a                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Subjects {#s4-1}
--------

C57BL/6J BAC transgenic mouse lines expressing Cre recombinase under control of dopamine D1R or D2R (*Drd1*-EY217 and *Drd2*-ER44, respectively) were obtained from Gene Expression Nervous System Atlas. The animals were extensively handled and then water-deprived so that their bodyweights were maintained at \~80% of ad libitum levels throughout the experiments. Each mouse was housed in an individual home cage, and all experiments were performed in the dark phase of a 12 hr light/dark cycle. A total of 31 D1R-Cre and 30 D2R-Cre mice were used for expression of h4DMi-mCherry in the striatum. Of these, 11 D1R-Cre and 11 D2R-Cre mice were tested in the reversal task only, 10 D1R-Cre and nine D2R-Cre mice were tested in the dynamic TAB task only, and 10 D1R-Cre and 10 D2R-Cre mice were tested in both the reversal and TAB tasks. The mice tested in the reversal task were assigned randomly to CNO- or DMSO-treatment groups. An additional five D1R-Cre and five D2R-Cre mice were used for expression of eGFP in the striatum and were tested in the reversal task only. Only male mice were used in the present study and all were 10--15 wk old at the time of virus injection surgery. All animal care and experimental procedures were performed in accordance with protocols approved by the directives of the Animal Care and Use Committee of Korea Advanced Institute of Science and Technology (approval number KA2018-08).

Virus injection {#s4-2}
---------------

Mice were anesthetized with isoflurane (1.0--1.2% \[vol/vol\] in 100% oxygen), and two burr holes were made bilaterally at 0.3 mm anterior and 2.0 mm lateral to bregma. AAV8-based, modified human M4 muscarinic receptor (AAV8-hSyn-DIO-hM4Di-mCherry; 31 D1R-Cre and 30 D2R-Cre mice) or AAV2-based enhanced green fluorescent protein (AAV2-hSyn-DIO-eGFP; five D1R-Cre and five D2R-Cre mice; Addgene) expression constructs were injected bilaterally at a depth of 3.0 mm from the brain surface at a rate of 0.05 μl/min (total volume, 2 μl). The injection needle was held in place for 15 min before and after the injection.

Behavioral tasks {#s4-3}
----------------

Animals were trained in self-paced instrumental learning tasks in an operant chamber (product \#ENV-307A; MED Associates, Fairfax, VT, USA). The chamber was customized to contain three nose-poke holes, each with an infrared photobeam sensor for detecting a nose poke and an LED, on the front wall. A water-delivery nozzle was also located inside each of the left and right nose-poke holes ([Figure 2a](#fig2){ref-type="fig"}). Each animal was tested in a reversal task and/or a dynamic TAB task. In both tasks, the session began by turning on the central LED. A nose poke in the central hole turned off the central LED and turned on the LEDs on both sides. The animal was free to choose between the two lit nose-poke holes at this stage. A nose poke in either the left or right hole turned off the left and right LEDs, triggered water delivery (30 μl) in some trials (correct-choice trials in the reversal task and stochastically with a given probability in the TAB task) at the chosen target, and turned on the center LED. Mice were acclimated to the chamber on day 1 (free exploration of the chamber for 1 hr without reward delivery) and experienced shaping training on day 2 (center LED on - \> nose poke - \> center LED off and side LEDs on - \> reward delivery on both sides; 60 trials or 1 hr) before being trained in the tasks.

The reversal task consisted of five stages with progressively increasing reversal frequency ([@bib29]) (one session per day). In the first stage, mice were trained to choose one target (either left or right; counterbalanced across animals) to obtain a water reward (30 μl). They performed 60 daily trials for 3 d. In the second stage, animals were trained to choose the opposite target (the unrewarded target in stage 1) for 4 d (60 daily trials). In the third stage, the location of the rewarding target changed from that of the previous day (across-session reversal). Third-stage training persisted for 4 d with 60 daily trials. In the fourth stage, in addition to changing the location of the rewarding target from that of the previous day, the location of the rewarding target was reversed midway through daily training (at trial 31; total daily trials, n = 60) for 4 d. In the final stage, in addition to changing the location of the rewarding target from that of the previous day, the location of the rewarding target was reversed twice during daily training (at trials 31 and 61; total daily trials, n = 90).

The dynamic TAB task consisted of four blocks of trials, each of which consisted of 35--50 trials (one session per day; 24 hr apart); DMSO and CNO were injected on alternate days, with the order of drug injection counterbalanced across animals. A total of 35, 40, 45 or 50 trials, determined randomly, were conducted per block (means ± SD: 38.8 ± 6.1 trials per block and 155.3 ± 16.0 trials per session). In each block, one target delivered water with a relatively high probability (72%) and the other target delivered water with a relatively low probability (12%). The reward probabilities in the first block were determined randomly and were reversed across block transitions.

Determination of dynamic and steady states {#s4-4}
------------------------------------------

Dynamic and steady states were determined separately for each block as previously described ([@bib22]). Animal choice data were smoothed using a moving average of seven trials. The dynamic state lasted until the probability of choosing the higher-reward--probability target (P(H)) exceeded 70% of the maximum value after block transition. The steady state corresponded to the period from the trial at which P(H) exceeded 90% of the maximum value until the end of the block. The mean (± SD across animals) numbers of trials for the dynamic state were 7.5 ± 4.4 for D1R-DMSO, 7.6 ± 5.0 for D1R-CNO, 8.4 ± 5.0 for D2R-DMSO, and 8.5 ± 7.3 for D2R-CNO. For the steady state, means ± SD were 9.6 0 ± 6.1 for D1R-DMSO, 9.5 ± 6.8 for D1R-CNO, 10.5 ± 6.8 for D2R-DMSO, and 10.4 ± 7.0 for D2R-CNO.

Reinforcement learning models {#s4-5}
-----------------------------

Animal choice behavior in the dynamic TAB task was analyzed using the Q-learning model ([@bib45]), in which action values in the *t*^th^ trial ($Q_{a}\left( t \right)$) were updated, as follows:$$\begin{matrix}
{if\, a = a(t),} & {Q_{a}\left( {t + 1} \right) = \left( {1 - \alpha} \right)Q_{a}\left( t \right) + \alpha R\left( t \right)} \\
{else} & {Q_{a}\left( {t + 1} \right) = Q_{a}(t),} \\
\end{matrix}$$where $a$ represents an action (left or right target choice), $R\left( t \right)$ denotes the reward (i.e., trial outcome) in the *t*^th^ trial (1 if rewarded and 0 otherwise), and α indicates the learning rate. Action selection was determined using a softmax function of the difference in action values $\left( Q_{L}\left( t \right) - Q_{R}\left( t \right) \right)$, as follows:$$P_{L}\left( t \right) = \frac{1}{1 + exp\left( {- \beta\left( {Q_{L}\left( t \right) - Q_{R}\left( t \right)} \right)} \right)},$$where *P~L~*(*t*) is the probability of choosing the left goal and *β* is the inverse temperature, which determines the degree of randomness in action selection (smaller *β* values induce more random choices).

We also analyzed animal choice behavior using several variants of the Q-learning model (model 1, parameters, α and β) by adding additional parameters and using separate learning constants for positive and negative outcomes (α~pos~ and α~neg~, respectively). Model two had a choice bias (V~L~) as an additional parameter (parameters, α, β and V~L~). Model three had separate learning constants for positive and negative outcomes, and also included a choice bias (parameters, α~pos~, α~neg~, β and V~L~). Model four had a choice bias, win-stay (WS), and lose-switch (LS) as additional parameters (parameters, α, β, V~L~, WS and LS). Model five had separate learning constants for positive and negative outcomes and included a choice bias, win-stay, and lose-switch (α~pos~, α~neg~, β, V~L~, WS and LS). All four models can be expressed by the following equations:$$\begin{matrix}
{{if}\, a = a(t),} & \\
{\qquad\begin{matrix}
{{if}\, R(t) = 1} & {Q_{a}(t + 1) = (1 - \alpha_{pos})Q_{a}(t) + \alpha_{pos}R(t) - \gamma\_ win} \\
{else} & {Q_{a}(t + 1) = (1 - \alpha_{neg})Q_{a}(t) + \alpha_{neg}R(t) - \gamma\_ lose} \\
\end{matrix}} & \\
{else} & \\
{\qquad Q_{a}(t + 1) = Q_{a}(t),} & \\
\end{matrix}$$where $\alpha_{pos}$ and $\alpha_{neg}$ are learning rates for rewarded and unrewarded trials, respectively, and $\gamma\_ win$ and $\gamma\_ lose$ are the penalty terms for repeating the same choice. Actions were chosen according to the softmax action selection rule, as follows:$$P_{L}\left( t \right) = \frac{1}{1 + exp\left( {- \beta\left( {Q_{L}\left( t \right) - Q_{R}\left( t \right)} \right) + b} \right)},$$where $b$ is a bias term for selecting the left target. The following constraints were applied to these parameters for models 2--4: model 2, $\alpha_{pos} = \alpha_{neg}$,$\gamma_{win} = \gamma_{lose} = 0$; model 3,$\gamma_{win} = \gamma_{lose} = 0$; model 4,$\alpha_{pos} = \alpha_{neg}$.

In addition, for model 6, we added terms for uncertainty-based exploration (ε and ρ) ([@bib14]; [@bib29]) to model 5 (parameters, α~pos~, α~neg~, β, V~L~, WS, LS, ε and ρ). Details of the modeling are described in our previous paper ([@bib29]). Model parameters were estimated separately for each mouse and for each condition (DMSO or CNO injection) by pooling choice data of all sessions based on a maximum-likelihood procedure.

Statistical analysis {#s4-6}
--------------------

Sample sizes were determined based on the sample sizes used in our previous study ([@bib29]), in which performances of D1R- and D2R-knockout mice were compared with those of wild-type mice in similar behavioral tasks as used in the present study. Two-way ANOVA and Bonferroni post-hoc tests were used for group comparisons. All statistical tests were two-tailed. A p-value\<0.05 was used as the criterion for a statistically significant difference. Data are expressed as means ± SEM unless noted otherwise. The data were analyzed with Matlab software (The MathWorks, Inc, MA, USA). Raw data and code for reproducing this work are archived at Dryad (<https://doi.org/10.5061/dryad.4c80mn5>).
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Thank you for submitting your article \"Distinct roles of striatal direct and indirect pathways in value-based decision making\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Geoffrey Schoenbaum as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Ronald Calabrese as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Mehdi Khamassi (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In the current study, the authors test the role of the direct and indirect pathways in reversal learning in mice. D1 vs D2 neurons were inactivated via CNO during several variants of a reversal task. The results demonstrate clear reversal deficits overall, and modest differences in effects of inactivation of the two pathways. Modeling of the results suggested that the effects could be distinguished as reflecting learning versus the use of the new information.

Essential revisions:

Overall the reviewers agreed that the study addressed an important question and was well designed and executed. However the reviewers were ultimately split on whether the major novel conclusions -- the differential effects of inactivation of D1 vs D2 networks -- were robustly supported by the data. In particular the differential effects in Figure 3 were very modest and it was not clear that they would hold up to a more appropriate statistical analysis of the entire design (vs t-tests). This experiment also seemed to lack the CNO-only control for comparison. On the other hand, the modeling results were judged to be robust. As a result the novelty, and our invitation for a revision, rests largely on these modeling data.

So it is essential in any revision that concerns and questions in the review regarding these analyses be fully addressed, and that the writing of these analyses be made as accessible as possible. Ideally this might include a brief discussion of assumptions of these analyses. It is also important that the data in Figure 3 be analyzed appropriately. If the results are not statistically meaningful unless they are analyzed by a series of isolated t-tests, then this may be a problem on re-review. Finally some softening of the claims may help given the effect sizes; for instance is it certain that the functions are entirely dichotomous or does the dominance of one pathway *bias* the network toward one function versus the other?

*Reviewer \#1:*

In this study, the authors test effects of inhibition of striatal D1 and D2 neurons on performance in a choice task in which the mouse picked between two nosepoke responses on each trial to obtain reward. In the first task, one nosepoke was rewarded while the other was not, and this reversed across blocks of trials, first across and then within sessions. In the second task, the nosepokes were associated with high (72%) and low (12%) probability of reward, and the probabilities reversed in 4 trial blocks each session. The authors found that inhibition of either neuron type (via DREADD/CNO) caused marked reversal deficits in the first task relative to CNO alone and more subtle deficits in the second task. An analysis of performance early versus late in the second task revealed that D2 inhibition affected behavior early in a block and D1 inhibition affected behavior later. The authors interpreted this via modeling as reflecting completely dissociable roles of the two neural subtypes in learning versus using information about action values.

Overall this study addresses an important question, which is the respective roles of these two neural subtypes and circuits in value-based behavior. However I think the results have a number of problems that need to be corrected. One is that the key second experiment lacks any control for non-specific effects of CNO. This lack is mitigated by the inclusion of this control in the first experiment, but the second experiment is quite different and contains the key effects. So the lack of this control is a problem I think. That the two groups show different effects in the second experiment may mitigate this issue, but possibly one effect is CNO alone and the other is specific? In any event, the lack of this comparison is a problem and will be a criticism of the study.

A second procedural problem for me is the statistical analyses. Most of the comparisons are pairwise t-tests I think, and the effects are quite small. Do these comparisons stand up when done with ANOVAs or similar, looking for interactions, etc?

Two other issues for me are more interpretive. One is that I do not really see the clear dichotomy between the phases of the task and the cognitive functions. Obviously it *could* be as the authors say, but I don\'t think it *must* be as the authors say. Indeed similar claims have been made in the past -- Jones and Mishkin, 1972 for example argued that impairments after reversal prior to 50% performance reflected a failure to unlearn the old information whereas impairments after this point reflected a failure to learn the new information. Yet we know that old information can breakthrough days or weeks after it has apparently been unlearned (!). And new learning does not wait for unlearning. Likewise here it seems to me that a failure to adequately learn versus use information could appear as poor performance early or late, depending on other factors. So I think this is a potential interpretation of the finding but not the only one.

Another interpretive problem I have is that the authors used a manipulation that will affect activity constitutively, without regard to when the network is phasically active. Even though it is reversible, the effect of CNO will be across the entire trial and even session of course. The firing patterns of these neurons and particularly any interaction with dopamine circuits is obviously going to be time-varying. I think the conclusions should recognize this limitation.

Despite these concerns, I think the study is overall very nice and clearly provides novel findings bearing on a question of interest. I think if the above technical issues are addressable and the language softened a bit, it would make a nice report.

*Reviewer \#2:*

The authors present the results of D1-Cre or D2-Cre injections in mice for selectively inactivating D1R- or D2R-expressing dorsal striatal neurons, respectively in two different tasks: a reversal task with progressively increasing reversal frequency and a dynamic two-armed bandit task. 6 different reward-based learning models were fitted to the data and compared in order to assess which computational mechanisms may best explain the experimental data. Results show that inactivation of D1R- and D2R-expressing striatal neurons selectively impairs value-dependent action selection and value learning, respectively.

The results are to my knowledge novel, timely, and shed new light on a debate about the selective roles of D1R- and D2R- expressing striatal neurons in reward-based learning. In particular, previous studies using optogenetic stimulations had found dissociated effects of D1R- and D2R- stimulation on positive versus negative reinforcement (e.g., Kravitz et al., 2012). In constrast, some other studies had shown a role of D2R- but not D1R- stimulation in reward-based learning (e.g., Lee et al., 2015). And a few theories have argued for a role of dopamine in the basal ganglia on gain control for action selection, distinct from its role in learning, which is in agreement with the present results. I thus think that the present results bring important new insights into the understanding of other dopamine-related functions in the striatum than the classical implication in reward-based learning.

Below, I raise a few questions and make a few suggestions to improve the manuscript.

Results final paragraph: \'*Q~high~* was slightly higher during a few trials after block transition in CNO compared to DMSO sessions\' -\> Was this difference statistically significant?

In the Discussion, the authors try to argue against the possibility that \'D1R- and/or D2R- expressing striatal interneurons (GABAergic fast-spiking interneurons and cholinergic tonically-active neurons)\' might have contributed to the observed results. They discard this possibility by saying that only small fractions of interneurons were labeled here. Nevertheless, the percentage of labeled neurons might not be the crucial parameter if a few interneurons can have a massive effect on performance. I am not sure what the authors mean when they write that the interneurons were labeled \'in similar degrees in the D1-Cre and D2-Cre mice\'. I guess they mean non-different percentages of labeled interneurons between the two types of mice. If this is the case, first the authors should apply some statistical test to verify that there are no differences in proportions (e.g., chi-square proportion test). Second, this does not answer the question whether a small percentage of labeled interneurons may have had a strong contribution (at least not a negligible contribution compared to that of MSN neurons). Is there a way the authors can answer this question?

In the Discussion, I think the authors should also emphasize that a central theory (Frank et al., 2004) argues not only that D1R- and D2R- expressing striatal neurons both contribute to learning, but also that D1R-ones are involved in positive learning (GO) and D2R-ones are involved in negative learning (NO-GO). Here, the results show that D2R-expressing neurons are involved in both positive and negative learning. e.g., model fitting with distinct learning rates for positive and negative feedback show significant variations in both for D2-CNO compared to D2-DMSO (Figure 4---figure supplement 1). The same figure even shows that for the 2 models with higher degree complexity, it is only the positive learning rate which is affected for D2. I guess this is more complicated to interpret given the number of free parameters and possible interactions between parameters. Nevertheless, all this could be more extensively discussed in the manuscript.

The authors discuss the possible effects on action selection in terms of gain control by the basal ganglia over cortical motor commands (Yttri and Dudman, 2016, 2018). I think that to be fair, the authors should cite the first paper (to my knowledge) which proposed a role for dopamine in gain control: Servan-Schreiber, Printz and Cohen, 1990. Later, a computational model of incentive salience integrated a role of dopamine signals in the striatum in two different functions: reinforcement learning and gain control in a softmax function to decide whether to GO or not: McClure, Daw and Montague, 2003. However, this model did not extend the mechanism to decision-making between multiple actions. Later on, a theory of the role of dopamine in the basal ganglia on the exploration-exploitation trade-off was proposed, in direct extensions of this theoretical framework: Humphries, Khamassi and Gurney, 2012. In this theory, tonic dopamine directly modulates the inverse temperature (parameter β) in the softmax function for action selection. Importantly, Importantly, through neural network simulations, the latter theory predicted that tonic dopamine should regulate the exploration-exploitation trade-off specifically via D1R-expressing striatal neurons, not D2R-ones. The present results are in perfect accordance with this theory and bring further insights on the functional dissociation between D1R- and D2R-expressing striatal neurons.

In subsection "Reinforcement learning models", in order to better appraise the different mechanisms in the compared computational models, it is important to show the equations for each of them. For instance, I bet that the choice bias VL, and win-stay lose-shift parameters WS and LS play a role via the softmax equation 2. But it is better to make this explicit by showing how the equations change for each of the tested models.

*Reviewer \#3:*

In this paper, the authors aimed to determine how direct and indirect pathway MSNs work in tandem to influence choice behavior. The manuscript was well written, and the experiments were executed thoroughly. They show that inhibiting D1 or D2 MSNs disrupted reversal learning (Figure 2), which was the largest effect they observed. The data looks very convincing on this point.

Upon parsing their data further (Figure 3 and 4), the authors report a difference in DREADD mediated inhibition of D2 vs D1-MSNs in early vs late trials per block, respectively. The authors interpret this as a difference in \"value based action selection\" (early trials) vs. \"value based updating\" (late trials). I was not convinced that this operational definition was reasonable, as it seemed a bit arbitrary to define the early trials as one component of the decision making process and the late trials as another. To make such claims the authors would likely need to utilize different tasks that specifically engaged each process as independently as possible.

Beyond this issue, the difference in each pathway that they observed in this part of the paper were very small, on the order of 5-10% changes in behavior, and trending in the same direction (impaired performance with CNO) in both phases, for both groups (Figure 3). From the figure legend, it appears that the authors analyzed this data with multiple paired t-tests instead of ANOVAs, which is not appropriate in a multiple comparison design like this. My suspicion is that if the data were analyzed by ANOVA it would reveal no effect of group between these measures.

Overall, I thought there was far more similarity than differences in the effects of manipulating each pathway, and found a dissonance between the data and the language used in the paper, which sought to highlight differences, concluding that \"D1R- and D2R-expressing striatal neurons selectively impairs value-dependent action selection and value learning, respectively.\" Though the data is promising and raises interesting questions, it alone is insufficient to conclude that D2 MSN activity underlies value-based learning and D1 underlies action-selection.

As it currently stands, this work presents an exciting initial phase of a project but I believe it is insufficient for publication as a stand-alone manuscript in *eLife*.

\[Editors' note: this article was subsequently rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"Distinct roles of striatal direct and indirect pathways in value-based decision making\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Geoffrey Schoenbaum as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by a Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Mehdi Khamassi (Reviewer \#2).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

This decision was reached by consensus across the three reviewers, in reading the revision and during the interactive discussion. The main problem was that the key statistical comparisons did not support the dissociation that was the basis of the modeling and the heart of the paper. Two of the three reviewers noted this as an essential revision on evaluating the original manuscript, and on discussion of the revision, all three reviewers agreed that the issue had not been corrected in the revision. While the modeling was judged to be interesting, it was not argued to be enough of an advance on its own to publish without clear biological support for the claimed dichotomy in the function of the D1 and D2 systems. And while additional subjects might be added to correct this shortcoming, the policy at *eLife* is not to request additional experiments of prolonged duration. We are very sorry for the negative outcome.

*Reviewer \#1:*

I was disappointed in the revisions I am afraid. The key issue is that the statistical assessment on Figure 3 did not support the claimed dissociation that lead to the modeling. The bidirectional effects are exceedingly small in the two directions and without full statistical support for the dissociation, I think it becomes questionable whether the biological system even shows the effect that is modeled.. Additionally the other concerns were addressed in relatively marginal ways. This did not help, but was not a determining factor. If the statistics were strong and the dissociation was robust, I would have found it acceptable I think. But I think the paper really hinges on this comparison. I am very sorry that I cannot be more positive.

*Reviewer \#2:*

The authors have addressed all my concerns.

*Reviewer \#3:*

I thank the authors for being responsive to the reviewer comments, and for re-analyzing the data in Figure 3. In my prior review I had two main concerns:

1\) The authors analyzed the data in Figure 3 with many paired t-tests instead of an ANOVA.

2\) I found the conclusions about differences between the two pathways to be over-stated, as they were based on relatively small effects and an improper statistical analysis.

The authors were responsive to the statistical concern, and now analyze data in Figure 3 with ANOVAs. This confirmed that several of their prior conclusions on these pathways were not significant when analyzed this way. In this reanalysis, they first analyzed the entire behavioral dataset with four individual ANOVAs (with no correction for multiple comparisons). They now find no significant interaction between drug x mouse line for the proportion of rewarded trials (P(R)), higher-reward-probability target choices (P(H)), probability of win-stay (P(WS)). They did detect a significant interaction between drug x mouse line for the probability of lost-stay (P (LS), p=0.019). Without a prior hypothesis pointing them to lose-stay behavior, I think it would be reasonable to correct their α, which limits my enthusiasm for the interaction with p=0.019. If they performed a Bonferoni correction to avoid Type I error, their α would be 0.0125. Even with a more lenient correction it is likely that this interaction would be on the border of significance.

They continue to parse the behavioral data into early and late trials. Here, they now perform 8 separate ANOVAs (same as above but done separate for early and late trials), again with no correction for multiple comparisons. In the early (dynamic) phase, they found a significant drug x mouse line interaction in P(R) (p=0.04), but not on any other measure. In the late (static) phase, there were significant drug x mouse line interactions on P(H) (p=0.029) and P(LS) (p=0.005). Based on the number of analyses performed on the same underlying data, some α correction should be used. If they performed a Bonferoni correction to avoid Type I error, their α would be 0.0042 and none of these would be considered significant. If they used a correction method that was less aggressive against Type I error, it is unlikely that any beyond the P(LS) in the dynamic phase would be significant.

Based on these new analyses, my first concern stands, in that the prior reporting of differences was due in part to the use of inappropriate statistical analysis. Unfortunately this is still the case, as no corrections were made for multiple comparisons when running several ANOVAs on different aspects of the same dataset. Based on this new statistical analysis and interpretation, I still find the conclusions of the paper to be over-interpreted. The Abstract and title highlight the differences between these pathways, when in almost every condition inhibition of either pathway caused a similar pattern of behavioral impairment.

One way I would be convinced that there\'s a force greater than chance at work here would be if the authors performed a permutation analysis on this same dataset. If they randomize which group each animal belongs to and re-run their 12 ANOVAs, how many ANOVAs show a significant interaction between drug x mouse line?

10.7554/eLife.46050.016

Author response

> Essential revisions:
>
> Overall the reviewers agreed that the study addressed an important question and was well designed and executed. However the reviewers were ultimately split on whether the major novel conclusions -- the differential effects of inactivation of D1 vs D2 networks -- were robustly supported by the data. In particular the differential effects in Figure 3 were very modest and it was not clear that they would hold up to a more appropriate statistical analysis of the entire design (vs t-tests). This experiment also seemed to lack the CNO-only control for comparison. On the other hand, the modeling results were judged to be robust. As a result the novelty, and our invitation for a revision, rests largely on these modeling data.

*So it is essential in any revision that concerns and questions in the review regarding these analyses be fully addressed, and that the writing of these analyses be made as accessible as possible. Ideally this might include a brief discussion of assumptions of these analyses. It is also important that the data in Figure 3 be analyzed appropriately. If the results are not statistically meaningful unless they are analyzed by a series of isolated t-tests, then this may be a problem on re-review. Finally some softening of the claims may help given the effect sizes; for instance is it certain that the functions are entirely dichotomous or does the dominance of one pathway* bias *the network toward one function versus the other?*

We addressed these legitimate concerns in our revised manuscript. Please see our responses to individual comments below. Briefly, we replaced t-tests with two-way ANOVA, discussed the CNO-control issue, and softened our claim on specific roles of direct-and indirect-pathway neurons.

Reviewer \#1:

> \[...\] Overall this study addresses an important question, which is the respective roles of these two neural subtypes and circuits in value-based behavior. However I think the results have a number of problems that need to be corrected. One is that the key second experiment lacks any control for non-specific effects of CNO. This lack is mitigated by the inclusion of this control in the first experiment, but the second experiment is quite different and contains the key effects. So the lack of this control is a problem I think. That the two groups show different effects in the second experiment may mitigate this issue, but possibly one effect is CNO alone and the other is specific? In any event, the lack of this comparison is a problem and will be a criticism of the study.

As the reviewer noted, that CNO selectively affects learning rate in D1-Cre mice and randomness in action selection in D2-Cre mice argues against non-specific effects of CNO. A non-specific effect of CNO, if any, should be observed in both animal groups (e.g., learning rate is lowered in both animal groups). We also obtained consistent results in our previous study. CNO impaired learning rate in only one of four different animal groups expressing hM4Di in different hippocampal subregions, while having no significant effect on learning rate or randomness in action selection in the remaining three animal groups during a dynamic two-armed bandit task (Jeong et al., 2018).We briefly discussed this matter in the revised manuscript.

> A second procedural problem for me is the statistical analyses. Most of the comparisons are pairwise t-tests I think, and the effects are quite small. Do these comparisons stand up when done with ANOVAs or similar, looking for interactions, etc?

We replaced t-tests with two-way ANOVAand obtained largely similar results. Two-way ANOVA yielded similar conclusions for the analyses shown in Figure 2 and 4. Regarding Figure 3, as expected, we failed to obtain significant interaction effects for some measures that showed selectivity in CNO effect between D1-Cre and D2-Cre mice upon t-tests. Nevertheless, we found CNO effects that are selective between D1-Cre and D2-Cre mice for some behavioral measures. We found that CNO significantly decreases P(R) in D2-Cre, but not D1-Cre, mice in the dynamic state, and significantly decreases P(H), P(WS) and P(LS) in D1-Cre, but not D2-Cre, mice in the steady state (revised Figure 3).These results support the possibility that D1R-and D2R-expressing striatal neurons contribute differently to the neural processes underlying the animal's choice behavior.

*Two other issues for me are more interpretive. One is that I do not really see the clear dichotomy between the phases of the task and the cognitive functions. Obviously it* could *be as the authors say, but I don\'t think it* must *be as the authors say. Indeed similar claims have been made in the past -- Jones and Mishkin, 1972 for example argued that impairments after reversal prior to 50% performance reflected a failure to unlearn the old information whereas impairments after this point reflected a failure to learn the new information. Yet we know that old information can breakthrough days or weeks after it has apparently been unlearned (!). And new learning does not wait for unlearning. Likewise here it seems to me that a failure to adequately learn versus use information could appear as poor performance early or late, depending on other factors. So I think this is a potential interpretation of the finding but not the only one.*

We fully agree with the reviewer's comment, and we by no means meant to equate early-and late-phase inactivation effects with deficits in value learning and value-based action selection, respectively. Value learning and value-dependent action selection are presumably always at work. What we try to argue is that effects of manipulating value-learning vs. value-dependent action selection processes on the animal's choice behavior would be relatively more pronounced during early and late trials after block transition, respectively. To avoid misunderstanding, we revised the text related to Figure 3 as the following:

"To further explore this possibility, we separately analyzed animal choice behavior in the dynamic and steady states (early and late trials after block transition, respectively; see Materials and methods) between which relative contributions of value-updating and value-dependent action-selection processes to choice behavior are likely to vary."

We also revised the text related to Figure 4 as the following:

"Differences in the pattern of CNO effects on animal choice behavior during dynamic and steady states between D1-Cre and D2-Cre mice raises the possibility that D1R-and D2R-expressing striatal neurons may contribute differently to the neural processes underlying value-based decision making."

> Another interpretive problem I have is that the authors used a manipulation that will affect activity constitutively, without regard to when the network is phasically active. Even though it is reversible, the effect of CNO will be across the entire trial and even session of course. The firing patterns of these neurons and particularly any interaction with dopamine circuits is obviously going to be time-varying. I think the conclusions should recognize this limitation.

We agree and discussed this matter in the revised text.

> Despite these concerns, I think the study is overall very nice and clearly provides novel findings bearing on a question of interest. I think if the above technical issues are addressable and the language softened a bit, it would make a nice report.

Thank you for these positive comments. We de-emphasized our claim on specific roles of direct and indirect pathway neurons throughout the revised manuscript.

Reviewer \#2:

> \[...\] The results are to my knowledge novel, timely, and shed new light on a debate about the selective roles of D1R- and D2R- expressing striatal neurons in reward-based learning. In particular, previous studies using optogenetic stimulations had found dissociated effects of D1R- and D2R- stimulation on positive versus negative reinforcement (e.g., Kravitz et al., 2012). In constrast, some other studies had shown a role of D2R- but not D1R- stimulation in reward-based learning (e.g., Lee et al., 2015). And a few theories have argued for a role of dopamine in the basal ganglia on gain control for action selection, distinct from its role in learning, which is in agreement with the present results. I thus think that the present results bring important new insights into the understanding of other dopamine-related functions in the striatum than the classical implication in reward-based learning.

Thank you for these positive comments.

> Below, I raise a few questions and make a few suggestions to improve the manuscript.
>
> Results final paragraph: \'Q~high~ was slightly higher during a few trials after block transition in CNO compared to DMSO sessions\' -\> Was this difference statistically significant?

*Q~high~* was significantly higher in CNO sessions compared with DMSO sessions in the second and third trials after block transition in D1-Cre mice(Bonferroni post-hoc tests following two-way repeated measures ANOVA). This is indicated with asterisks in Figure 4B (left, line graph).

> In the Discussion, the authors try to argue against the possibility that \'D1R- and/or D2R- expressing striatal interneurons (GABAergic fast-spiking interneurons and cholinergic tonically-active neurons)\' might have contributed to the observed results. They discard this possibility by saying that only small fractions of interneurons were labeled here. Nevertheless, the percentage of labeled neurons might not be the crucial parameter if a few interneurons can have a massive effect on performance. I am not sure what the authors mean when they write that the interneurons were labeled \'in similar degrees in the D1-Cre and D2-Cre mice\'. I guess they mean non-different percentages of labeled interneurons between the two types of mice. If this is the case, first the authors should apply some statistical test to verify that there are no differences in proportions (e.g., chi-square proportion test). Second, this does not answer the question whether a small percentage of labeled interneurons may have had a strong contribution (at least not a negligible contribution compared to that of MSN neurons). Is there a way the authors can answer this question?

We agree that a small percentage of labeled interneurons may exert relatively strong influences on behavior. As suggested, we performed Fisher's exact test and found no significant difference in the number of labeled interneurons between D1-Cre and C2-Cre mice (see Figure 1---figure supplement 1). In fact, their proportions were very similar (PV, 2.7and 2.3%, respectively; ChaT, 6.3 and 6.4%, respectively). Hence, any effect of inactivating labeled interneurons on the animal's behavior would have been similar between D1-Cre and D2-Cre mice. Given the reviewer's comment, we revised the related text from "This is unlikely because only small fractions of parvalbumin-positive (\< 3%) and choline acetyltransferase-positive (\< 7%) striatal neurons are labelled and in similar degrees in the D1-Cre and D2-Cre mice" to "However, this is unlikely because similar, small percentages of parvalbumin-positive and choline acetyltransferase-positive striatal neurons are labelled in D1-Cre and D2-Cre mice".

> In the Discussion, I think the authors should also emphasize that a central theory (Frank et al., 2004) argues not only that D1R- and D2R- expressing striatal neurons both contribute to learning, but also that D1R-ones are involved in positive learning (GO) and D2R-ones are involved in negative learning (NO-GO). Here, the results show that D2R-expressing neurons are involved in both positive and negative learning. e.g., model fitting with distinct learning rates for positive and negative feedback show significant variations in both for D2-CNO compared to D2-DMSO (Figure 4---figure supplement 1). The same figure even shows that for the 2 models with higher degree complexity, it is only the positive learning rate which is affected for D2. I guess this is more complicated to interpret given the number of free parameters and possible interactions between parameters. Nevertheless, all this could be more extensively discussed in the manuscript.

As suggested, we discussed this matter in the revised text. Please note that new analysis results (two-way ANOVA) indicate significant effect of D2R neuronal inactivation on only positive learning rate in all models tested.

> The authors discuss the possible effects on action selection in terms of gain control by the basal ganglia over cortical motor commands (Yttri and Dudman, 2016, 2018). I think that to be fair, the authors should cite the first paper (to my knowledge) which proposed a role for dopamine in gain control: Servan-Schreiber, Printz and Cohen, 1990. Later, a computational model of incentive salience integrated a role of dopamine signals in the striatum in two different functions: reinforcement learning and gain control in a softmax function to decide whether to GO or not: McClure., Daw and Montague, 2003. However, this model did not extend the mechanism to decision-making between multiple actions. Later on, a theory of the role of dopamine in the basal ganglia on the exploration-exploitation trade-off was proposed, in direct extensions of this theoretical framework: Humphries, Khamassi and Gurney, 2012. In this theory, tonic dopamine directly modulates the inverse temperature (parameter β) in the softmax function for action selection. Importantly, Importantly, through neural network simulations, the latter theory predicted that tonic dopamine should regulate the exploration-exploitation trade-off specifically via D1R-expressing striatal neurons, not D2R-ones. The present results are in perfect accordance with this theory and bring further insights on the functional dissociation between D1R- and D2R-expressing striatal neurons.

Yes, it would be fair to cite these literatures. They are now cited and discussed in the revised text.

> In subsection "Reinforcement learning models", in order to better appraise the different mechanisms in the compared computational models, it is important to show the equations for each of them. For instance, I bet that the choice bias VL, and win-stay lose-shift parameters WS and LS play a role via the softmax equation 2. But it is better to make this explicit by showing how the equations change for each of the tested models.

Done as suggested except the last model (model 6).The model 6 contains terms for uncertainty-based exploration (ɛ and p)which require somewhat lengthy descriptions. Given that CNO effects on uncertainty-based exploration are not the main focus of our study and that the model 6 is fully described in our previous paper (Kwak et al., 2014), we referred to previous papers (Frank et al., 2009; Kwak et al., 2014) instead of elaborating all the related equations.

Reviewer \#3:

> In this paper, the authors aimed to determine how direct and indirect pathway MSNs work in tandem to influence choice behavior. The manuscript was well written, and the experiments were executed thoroughly. They show that inhibiting D1 or D2 MSNs disrupted reversal learning (Figure 2), which was the largest effect they observed. The data looks very convincing on this point.
>
> Upon parsing their data further (Figure 3 and 4), the authors report a difference in DREADD mediated inhibition of D2 vs D1-MSNs in early vs late trials per block, respectively. The authors interpret this as a difference in \"value based action selection\" (early trials) vs. \"value based updating\" (late trials). I was not convinced that this operational definition was reasonable, as it seemed a bit arbitrary to define the early trials as one component of the decision making process and the late trials as another. To make such claims the authors would likely need to utilize different tasks that specifically engaged each process as independently as possible.

We agree with the reviewer's comment. Reviewer \#1 also raised a similar concern. Please see our response to the third comment of reviewer \#1.

> Beyond this issue, the difference in each pathway that they observed in this part of the paper were very small, on the order of 5-10% changes in behavior, and trending in the same direction (impaired performance with CNO) in both phases, for both groups (Figure 3). From the figure legend, it appears that the authors analyzed this data with multiple paired t-tests instead of ANOVAs, which is not appropriate in a multiple comparison design like this. My suspicion is that if the data were analyzed by ANOVA it would reveal no effect of group between these measures.

We replaced t-tests with two-way ANOVAas suggested. As the reviewer predicted, we failed to obtain significant interaction effects for some measures that showed selectivity in CNO effect between D1-Cre and D2-Cre mice upon t-tests. Nevertheless, we found CNO effects that are selective between D1-Cre and D2-Cre mice in some behavioral measures. CNO significantly decreases P(R) in D2-Cre, but not D1-Cre, mice in the dynamic state, and significantly decreases P(H), P(WS) and P(LS) in D1-Cre, but not D2-Cre, mice in the steady state. As we indicated in our response to the third comment of reviewer \#1, value updating and value-dependent action selection are presumably always at work. Hence, effects of manipulating value-learning vs. value-dependent action-selection processes on the animal's choice behavior would be relatively more pronounced during early and late trials after block transition, respectively, rather than being exclusive. Hence, deficits in these processes are expected to influence choice behavior during early and late trials in the same direction. Also, the probabilistic nature of the task (rather than correct vs. incorrect choices) is likely to have contributed to overall small effect sizes when the animal's behavior (rather than its underlying processes) is examined (Figure 3). In addition, partial inactivation of striatum, which is a large structure, may have contributed to overall small effect sizes. Nevertheless, CNO effects were quite consistent across animals so that we could find significant and selective CNO effects on some measures upon pairwise comparisons (repeated-measures ANOVA).

> Overall, I thought there was far more similarity than differences in the effects of manipulating each pathway, and found a dissonance between the data and the language used in the paper, which sought to highlight differences, concluding that \"D1R- and D2R-expressing striatal neurons selectively impairs value-dependent action selection and value learning, respectively.\" Though the data is promising and raises interesting questions, it alone is insufficient to conclude that D2 MSN activity underlies value-based learning and D1 underlies action-selection.

Please note that our model-based analysis yielded a clear double dissociation in the effects of CNO treatment on learning rate and randomness in action selection(Figure 4). It is true that there are similarities between D1 and D2 MSN inactivation effects on behavioral measures(Figure 3). Note, however, that changes in two different underlying processes can lead to similar changes in the final end product (i.e., choice behavior).Conversely, differential effects of two manipulations on the final end product indicate differential effects of manipulation on the underlying processes. Considering that the task is probabilistic in nature (small manipulation effect) and value learning and value-based action selection are presumably always operating(relatively rather than absolutely stronger/weaker manipulation effects at early vs. late trials), it is remarkable that differential effects of D1 vs. D2 MSN inactivation could be detected even by examining the final end product (behavioral variables).

\[Editors' note: the author responses to the re-review follow.\]

The main criticism during the second round of review is that our statistical test results in Figure 3 do not support our claimed dissociation of inhibition effects between D1-Cre and D2-Cre mice. Specifically, the reviewer \#3 pointed out that the lack of Bonferroni correction for multiple ANOVAs is problematic. The reviewer \#3 then suggested a permutation test as an alternative way of testing the significance of our results.

We agree this is a legitimate concern. Even though we showed significant interaction effects in multiple ANOVAs (3 out of 8 ANOVAs; 4 out of 12 ANOVAs if we include all-trial analysis results), we did not test whether this is significant. We consulted a biostatistician and were advised to use the permutation test the reviewer \#3 suggested. We were told that correcting for multiple comparisons would be inappropriate for our data set (insufficient statistical power to reach a stringent threshold). Instead, testing the likelihood of finding significant interaction effect in 3 or more ANOVAs would a legitimate way of testing the significance of our results. As suggested by the reviewer \#3, we randomly assigned D1-cre and D2-mice into two animal groups and repeated the same analysis (total 8 ANOVAs; P(R), P(H), P(WS) and P(LS) in the dynamic and steady states). Out of 100 such permutations, we found no case in which significant animal group\*drug interaction effect was found in 3 or more ANOVAs (c.f., we found 3 cases in which significant interaction effect was found in 2 ANOVAs). Similar results were obtained when we performed a permutation test for 12 ANOVAs including all-trial data; we found no case in which significant animal group\*drug interaction effect was found in 4 or more ANOVAs out of 100 permutations (c.f., we found 1 case in which significant interaction effect was found in 3 ANOVAs). These new results indicate that our results are unlikely to be obtained by chance.

Given that the new analysis results address the main criticism, we are wondering whether you would be willing to re-consider your decision. We believe that it would be quite beneficial to share our data with the neuroscience community and stimulate further studies along this line.

Reviewer \#1:

> I was disappointed in the revisions I am afraid. The key issue is that the statistical assessment on Figure 3 did not support the claimed dissociation that lead to the modeling. The bidirectional effects are exceedingly small in the two directions and without full statistical support for the dissociation, I think it becomes questionable whether the biological system even shows the effect that is modeled.. Additionally the other concerns were addressed in relatively marginal ways. This did not help, but was not a determining factor. If the statistics were strong and the dissociation was robust, I would have found it acceptable I think. But I think the paper really hinges on this comparison. I am very sorry that I cannot be more positive.

As we explained in the cover letter and the response to the comment of reviewer \#3, we performed the permutation test suggested by the reviewer \#3 and obtained results indicating that our findings in Figure 3 are highly significant. We agree that the effects shown in Figure 3 are small. However, this is not very surprising because 1) the task is probabilistic in nature, 2) value learning and value-based action selection are presumably always operating (relatively rather than absolutely stronger/weaker manipulation effects at early vs. late trials), and 3) the striatum is a large structure and we only partially inactivated striatum. Given that CNO effects on overall P(R) and P(H) (all-trial analysis) were very similar between D1-Cre and D2-Cre mice, it is remarkable that differential effects of D1 vs. D2 neuronal inactivation could be detected on behavioral measures when we divided trials into early (dynamic state) and late (steady state).

Reviewer \#3:

> \[...\] They continue to parse the behavioral data into early and late trials. Here, they now perform 8 separate ANOVAs (same as above but done separate for early and late trials), again with no correction for multiple comparisons. In the early (dynamic) phase, they found a significant drug x mouse line interaction in P(R) (p=0.04), but not on any other measure. In the late (static) phase, there were significant drug x mouse line interactions on P(H) (p=0.029) and P(LS) (p=0.005). Based on the number of analyses performed on the same underlying data, some α correction should be used. If they performed a Bonferoni correction to avoid Type I error, their α would be 0.0042 and none of these would be considered significant. If they used a correction method that was less aggressive against Type I error, it is unlikely that any beyond the P(LS) in the dynamic phase would be significant.
>
> Based on these new analyses, my first concern stands, in that the prior reporting of differences was due in part to the use of inappropriate statistical analysis. Unfortunately this is still the case, as no corrections were made for multiple comparisons when running several ANOVAs on different aspects of the same dataset. Based on this new statistical analysis and interpretation, I still find the conclusions of the paper to be over-interpreted. The Abstract and title highlight the differences between these pathways, when in almost every condition inhibition of either pathway caused a similar pattern of behavioral impairment.
>
> One way I would be convinced that there\'s a force greater than chance at work here would be if the authors performed a permutation analysis on this same dataset. If they randomize which group each animal belongs to and re-run their 12 ANOVAs, how many ANOVAs show a significant interaction between drug x mouse line?

Many thanks for elaborating issues related to statistics and suggesting an alternative way of testing the significance of our results. We consulted a biostatistician and were told that the permutation test you suggested would be a legitimate way of testing the significance of our results. As suggested, we randomly assigned D1-cre and D2-mice into two animal groups and repeated the same analysis (total 8 ANOVAs; P(R), P(H), P(WS) and P(LS) in the dynamic and steady states). Out of 100 such permutations, we found no case in which significant animal group x drug interaction effect was found in 3 or more ANOVAs (c.f., we found 3 cases in which significant interaction effect was found in 2 ANOVAs). This new result is described in the revised text (L 218). Results were similar when we performed a permutation test for 12 ANOVAs (additional 4 ANOVAs for P(R), P(H), P(WS) and P(LS) for all trials); we found no case in which significant animal group x drug interaction effect was found in 4 or more ANOVAs out of 100 permutations (c.f., we found 1 case in which significant interaction effect was found in 3 ANOVAs). This indicates that our results are unlikely to be obtained by chance. Regarding your comment on the interaction effect in P(LS) (all-trial analysis), we agree that it is at best a weak effect and therefore deleted the related text in the revised manuscript (see new Figure 3).
